11:29 AM EST - Knight Therapeutics Inc. : Today reported financial results for its fourth quarter ended December 31, 2025. Revenues were $450,088, an increase of $78,784 or 21% over the prior year. Net loss was $5,374, compared to a net income of $4,332 in prior year.. Knight Therapeutics Inc.
shares T.GUD are trading up $0.05 at $6.22.
